vers la météo de la validation par utilisateur

Ingenuity255


precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 73 - PMID ?

In liver from male __SP__ , dietary administration of 70 kd __NODE__ ( with a dosage of 70.5 percent and a treatment period of 3 weeks ) increases expression of __SP__ __NODE__ mRNA that is decreased 3 fold by dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 3 weeks ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 3 weeks ) 3 weeks after initial treatment .


Non annotée
Je ne sais pas
Je n'ai pas trouvé d'analyse satisfaisante


Commentaires :

Analyse 0
                                                                                                                                                                                                                                                                              +------------------------COMP:N-N(of)-----------------------+                                                                                                                       
                                                                                                                                                                                                                                                                              +-----------COMP:N-N(of)-----------+                        |                               +-------------COMP:N-N(of)------------+                                                 
      +----------------APPOS----------------+-------------------------------------COMP:N-N(with)------------------------------------+                                +-----------OBJ:V-N-----------+                                                              +------------COMP:N-N(of)-----------+------------COMP:N-N(of)-----------+                               |           +------------COMP:N-N(of)------------+                                      
      +-COMP:N-N(from)-+                    |                                     +-COMP:N-N(of)-+                                  +----------COMP:N-N(of)----------+              +---SUBJ:V-N---+---------COMP:V-N(by)---------+-------------APPOS-------------+COMP:N-N(of+                       +COMP:N-N(o+                        +-------------APPOS-------------+           |                         +COMP:N-N(o+--------COMP:N-N(after)--------+      
      |          +MOD_A+                    |                                     |        +MOD_A+                       +COMP:N-N(o+         +MOD_ATT:N-+           |       +MOD_AT+SUBJ:V-N+     |     +SUB+        +MOD_ATT:N-A+-COMP:N-N(of)-+                |      +MOD_+              +MOD_ATT:+      +MOD+            +MOD_ATT:N-A+-COMP:N-N(of)-+                +COMP:N-N(of+                +MOD_ATT:+      +MOD+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |                    |                                     |        |     |                       |          |         |          |           |       |      |        |     |     |   |        |           |              |                |      |    |              |        |      |   |            |           |              |                |           |                |        |      |   |     |   |     |      |        |      
 In liver from male __SP__ , dietary administration of 70 kd __NODE__ ( with a dosage of 70.5 percent and a treatment period of 3 weeks ) increases expression of __SP__ __NODE__ mRNA that is decreased 3 fold by dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 3 weeks ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 3 weeks ) 3 weeks after initial treatment .
COMP:N-N(from) (liver,__SP__)
APPOS (liver,administration)
MOD_ATT:N-ADJ (__SP__,male)
COMP:N-N(with) (administration,week)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (period,week)
COMP:N-N(of) (week,__SP__)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,mRNA)
COMP:V-N(by) (decrease,administration)
SUBJ:V-N (fold,3)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,dosage)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,1)
COMP:N-N(of) (percent,week)
COMP:N-N(of) (percent,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-ADJ (week,3)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,dosage)
COMP:N-N(of) (dosage,00.2percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (00.2percent,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,3)
COMP:N-N(after) (week,treatment)
MOD_ATT:N-ADJ (week,3)
MOD:ADV-N (after,week)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 1
                                                                                                                                                         +--------------SUBJ:V_PASS-N--------------+                                                                                                                                                                                                                                                              
                                            +------------COMP:N-N(with)-----------+-----------------------------COMP:N-N(of)-----------------------------+-------COMP:N-N(of)-------+              |                                             +-------------------COMP:N-N(with)-------------------+------------COMP:N-N(of)-----------+                                                                                                                       
                                            +-------OBJ:V-N------+                |                                                 +-----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ+              |         +----COMP:V-N(by)----+              |                +COMP:N-N(of+                       +COMP:N-N(o+--------------COMP:N-N(of)-------------+                +-------------COMP:N-N(of)------------+COMP:N-N(o+--------COMP:N-N(after)--------+      
      +----------------APPOS----------------+           +SUBJ:V-N+                +COMP:N-N+                    +MOD_ATT:+          |         +MOD_ATT:N-+           |       +MOD_AT+              |     +SUB+        +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+      +MOD_+              +MOD_ATT:+      +MOD+            +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+COMP:N-N(of+                +MOD_ATT:+      +MOD+     +MOD+MOD:A+      +MOD_ATT:+      
      |                                     |           |        |                |        |                    |        |          |         |          |           |       |      |              |     |   |        |           |              |                |      |    |              |        |      |   |            |           |              |                |           |                |        |      |   |     |   |     |      |        |      
 In liver from male __SP__ , dietary administration of 70 kd __NODE__ ( with a dosage of 70.5 percent and a treatment period of 3 weeks ) increases expression of __SP__ __NODE__ mRNA that is decreased 3 fold by dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 3 weeks ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 3 weeks ) 3 weeks after initial treatment .
APPOS (liver,administration)
COMP:N-N(with) (administration,dosage)
OBJ:V-N (__NODE__,administration)
SUBJ:V-N (__NODE__,@card@)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (dosage,expression)
MOD_ATT:N-N (period,treatment)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V_PASS-N (decrease,expression)
SUBJ:V-N (fold,3)
COMP:V-N(by) (fold,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(with) (__NODE__,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-ADJ (week,3)
COMP:N-N(of) (week,__NODE__)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (dosage,00.2percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,3)
COMP:N-N(after) (week,treatment)
MOD_ATT:N-ADJ (week,3)
MOD:ADV-N (after,week)
MOD_ATT:N-ADJ (treatment,initial)